Target intelligence / Profile preview

U6 snRNA-associated Sm-like protein LSm4 (LSM4)

Target
LSM4
Molecular classification
Other (Sm-like RNA-binding protein), RNA-binding protein, RNA decay complex subunit
01

Overview

LSM4 (U6 snRNA-associated Sm-like protein LSm4) is a member of the Sm-like protein family and is highly conserved in eukaryotes. It is an RNA-binding protein that forms part of several heptameric complexes involved in RNA metabolism, most notably the nuclear Lsm2-8 complex (essential for U6 snRNP biogenesis and pre-mRNA splicing) and the cytoplasmic Lsm1-7 complex (central to mRNA decapping and degradation, and processing body formation). The C-terminal region of LSM4 participates directly in histone mRNA degradation by interacting with mRNA binding proteins SLBP and 3′hExo. LSM4 rings assemble mainly via β-sheet and hydrophobic/salt bridge interactions. Dysregulation of LSM4, particularly overexpression, has been linked to enhanced tumorigenicity and poor outcomes in cancers such as ovarian and breast cancer. Although it has important roles in RNA processing and maintenance of RNA integrity, LSM4 is not currently considered a direct therapeutic target nor are there drugs that specifically modulate its activity. The biological consequences of LSM4 dysfunction are mainly due to disrupted RNA metabolism and splicing.

Other names
Glycine-rich proteinGRPYER112WU6 snRNA-associated Sm-like protein LSm4LSM4 homolog, U6 small nuclear RNA and mRNA degradation associatedLSM4 U6 small nuclear RNA and mRNA degradation associatedLSM4 homolog, U6 small nuclear RNA associated
02

Mechanism of action

Not applicable (no drugs targeting this molecule; mechanism relates inherently to RNA binding, RNA degradation, and spliceosome assembly, not to pharmacological action)

03

Biological functions

Pre-mRNA splicing: as a component of the U4/U6-U5 tri-snRNP and U6 snRNP complexes, LSM4 is essential for spliceosome assembly and RNA processingmRNA degradation: forms part of the cytoplasmic Lsm1–7 complex, facilitating the formation of processing bodies and promoting mRNA decapping and decayHistone mRNA degradation: the C-terminal region directly interacts with histone mRNP complexes to regulate rapid histone mRNA degradation, especially when DNA synthesis is inhibitedRNA metabolism: broader roles in processing and turnover of various RNA species
04

Disease associations

Cancer (overexpression is associated with poor prognosis and tumorigenic processes such as colony formation, migration, invasion, and glycolytic metabolism in cancers including ovarian and breast cancer)Other (RNA processing disruption may have roles in additional diseases, but specific involvement not clearly associated with therapeutic relevance)
05

Safety considerations

Not applicable (not a therapeutic target; no drug-specific safety concerns)As an RNA metabolism factor, broad inhibition could disrupt fundamental cellular processes
06

Interacting drugs

None known (no currently approved drugs or clinical candidates directly target LSM4)
07

Biomarkers

Elevated LSM4 expression may serve as a biomarker for poor prognosis in certain cancers (e.g., breast, ovarian)No established clinical biomarkers for patient selection or efficacy monitoring are in use

Beyond the preview

Go deeper on U6 snRNA-associated Sm-like protein LSm4 (LSM4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 snRNA-associated Sm-like protein LSm4 (LSM4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call